Close Menu

NEW YORK (GenomeWeb) – Researchers have teased out a gene expression program that is associated with resistance to immunotherapy in melanoma. Inhibiting this program could improve treatment response.

While immunotherapies like immune checkpoint inhibitors have led to sometimes-dramatic responses in a portion of cancer patients, others don't respond to the treatment.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.